お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、性機能障害治療薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に性機能障害治療薬市場を分類しています。
本レポートでは世界の性機能障害治療薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Pfizer、GlaxoSmithKline、Merck、Eli Lilly、AbbVie、Bayer、Teva Pharmaceutical Industries、Takeda、Apricus Biosciences、Emotional Brain、Ivix LLX、Leadiant Biosciences、NexMed、S1 Biopharma、Vietstar Biomedical Research

レポートは性機能障害治療薬の主要生産者を調査し、主要地域や国の消費状況も提供します。性機能障害治療薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Oral Therapy
    Intracavernosal Therapy
    Hormonal Therapy
    Transurethral Therapy

用途別の市場セグメント：
    Male
    Female

本レポートの詳細内容
本レポートは、世界の性機能障害治療薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて性機能障害治療薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の性機能障害治療薬生産量、成長率、市場シェアを調査している。

二. 消費面では、性機能障害治療薬の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの性機能障害治療薬売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の性機能障害治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本性機能障害治療薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：性機能障害治療薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 性機能障害治療薬の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける性機能障害治療薬の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章性機能障害治療薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：性機能障害治療薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：性機能障害治療薬の主要メーカーの概要を提供し、製品の説明と仕様、性機能障害治療薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：性機能障害治療薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
The global Sexual Dysfunction Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Sexual Dysfunction Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sexual Dysfunction Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sexual Dysfunction Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sexual Dysfunction Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sexual Dysfunction Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by User, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sexual Dysfunction Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, GlaxoSmithKline, Merck, Eli Lilly, AbbVie, Bayer, Teva Pharmaceutical Industries, Takeda and Apricus Biosciences, etc.

Market Segmentation
By Company
    Pfizer
    GlaxoSmithKline
    Merck
    Eli Lilly
    AbbVie
    Bayer
    Teva Pharmaceutical Industries
    Takeda
    Apricus Biosciences
    Emotional Brain
    Ivix LLX
    Leadiant Biosciences
    NexMed
    S1 Biopharma
    Vietstar Biomedical Research

Segment by Type
    Oral Therapy
    Intracavernosal Therapy
    Hormonal Therapy
    Transurethral Therapy

Segment by User
    Male
    Female

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Sexual Dysfunction Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by User, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by User and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by User and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by User, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by User and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by User and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sexual Dysfunction Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Sexual Dysfunction Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oral Therapy
    Table 3. Major Manufacturers of Intracavernosal Therapy
    Table 4. Major Manufacturers of Hormonal Therapy
    Table 5. Major Manufacturers of Transurethral Therapy
    Table 6. Global Sexual Dysfunction Drugs Market Size Growth Rate by User, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Sexual Dysfunction Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Sexual Dysfunction Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Sexual Dysfunction Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2019-2024)
    Table 11. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2025-2030)
    Table 12. Global Sexual Dysfunction Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Sexual Dysfunction Drugs Sales by Region (2019-2024) & (K Pcs)
    Table 14. Global Sexual Dysfunction Drugs Sales by Region (2025-2030) & (K Pcs)
    Table 15. Global Sexual Dysfunction Drugs Sales Market Share by Region (2019-2024)
    Table 16. Global Sexual Dysfunction Drugs Sales Market Share by Region (2025-2030)
    Table 17. Global Sexual Dysfunction Drugs Sales by Manufacturers (2019-2024) & (K Pcs)
    Table 18. Global Sexual Dysfunction Drugs Sales Share by Manufacturers (2019-2024)
    Table 19. Global Sexual Dysfunction Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Sexual Dysfunction Drugs Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Sexual Dysfunction Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Sexual Dysfunction Drugs Price by Manufacturers 2019-2024 (USD/Pcs)
    Table 23. Global Sexual Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Sexual Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2023)
    Table 25. Global Key Manufacturers of Sexual Dysfunction Drugs, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Sexual Dysfunction Drugs, Product Offered and Application
    Table 27. Global Key Manufacturers of Sexual Dysfunction Drugs, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Sexual Dysfunction Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 30. Global Sexual Dysfunction Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 31. Global Sexual Dysfunction Drugs Sales Share by Type (2019-2024)
    Table 32. Global Sexual Dysfunction Drugs Sales Share by Type (2025-2030)
    Table 33. Global Sexual Dysfunction Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Sexual Dysfunction Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Sexual Dysfunction Drugs Revenue Share by Type (2019-2024)
    Table 36. Global Sexual Dysfunction Drugs Revenue Share by Type (2025-2030)
    Table 37. Sexual Dysfunction Drugs Price by Type (2019-2024) & (USD/Pcs)
    Table 38. Global Sexual Dysfunction Drugs Price Forecast by Type (2025-2030) & (USD/Pcs)
    Table 39. Global Sexual Dysfunction Drugs Sales by User (2019-2024) & (K Pcs)
    Table 40. Global Sexual Dysfunction Drugs Sales by User (2025-2030) & (K Pcs)
    Table 41. Global Sexual Dysfunction Drugs Sales Share by User (2019-2024)
    Table 42. Global Sexual Dysfunction Drugs Sales Share by User (2025-2030)
    Table 43. Global Sexual Dysfunction Drugs Revenue by User (2019-2024) & (US$ Million)
    Table 44. Global Sexual Dysfunction Drugs Revenue by User (2025-2030) & (US$ Million)
    Table 45. Global Sexual Dysfunction Drugs Revenue Share by User (2019-2024)
    Table 46. Global Sexual Dysfunction Drugs Revenue Share by User (2025-2030)
    Table 47. Sexual Dysfunction Drugs Price by User (2019-2024) & (USD/Pcs)
    Table 48. Global Sexual Dysfunction Drugs Price Forecast by User (2025-2030) & (USD/Pcs)
    Table 49. US & Canada Sexual Dysfunction Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 50. US & Canada Sexual Dysfunction Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 51. US & Canada Sexual Dysfunction Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Sexual Dysfunction Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Sexual Dysfunction Drugs Sales by User (2019-2024) & (K Pcs)
    Table 54. US & Canada Sexual Dysfunction Drugs Sales by User (2025-2030) & (K Pcs)
    Table 55. US & Canada Sexual Dysfunction Drugs Revenue by User (2019-2024) & (US$ Million)
    Table 56. US & Canada Sexual Dysfunction Drugs Revenue by User (2025-2030) & (US$ Million)
    Table 57. US & Canada Sexual Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Sexual Dysfunction Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Sexual Dysfunction Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Sexual Dysfunction Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 61. US & Canada Sexual Dysfunction Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 62. Europe Sexual Dysfunction Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 63. Europe Sexual Dysfunction Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 64. Europe Sexual Dysfunction Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Sexual Dysfunction Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Sexual Dysfunction Drugs Sales by User (2019-2024) & (K Pcs)
    Table 67. Europe Sexual Dysfunction Drugs Sales by User (2025-2030) & (K Pcs)
    Table 68. Europe Sexual Dysfunction Drugs Revenue by User (2019-2024) & (US$ Million)
    Table 69. Europe Sexual Dysfunction Drugs Revenue by User (2025-2030) & (US$ Million)
    Table 70. Europe Sexual Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Sexual Dysfunction Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Sexual Dysfunction Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Sexual Dysfunction Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 74. Europe Sexual Dysfunction Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 75. China Sexual Dysfunction Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 76. China Sexual Dysfunction Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 77. China Sexual Dysfunction Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Sexual Dysfunction Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Sexual Dysfunction Drugs Sales by User (2019-2024) & (K Pcs)
    Table 80. China Sexual Dysfunction Drugs Sales by User (2025-2030) & (K Pcs)
    Table 81. China Sexual Dysfunction Drugs Revenue by User (2019-2024) & (US$ Million)
    Table 82. China Sexual Dysfunction Drugs Revenue by User (2025-2030) & (US$ Million)
    Table 83. Asia Sexual Dysfunction Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 84. Asia Sexual Dysfunction Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 85. Asia Sexual Dysfunction Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Sexual Dysfunction Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Sexual Dysfunction Drugs Sales by User (2019-2024) & (K Pcs)
    Table 88. Asia Sexual Dysfunction Drugs Sales by User (2025-2030) & (K Pcs)
    Table 89. Asia Sexual Dysfunction Drugs Revenue by User (2019-2024) & (US$ Million)
    Table 90. Asia Sexual Dysfunction Drugs Revenue by User (2025-2030) & (US$ Million)
    Table 91. Asia Sexual Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Sexual Dysfunction Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Sexual Dysfunction Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Sexual Dysfunction Drugs Sales by Region (2019-2024) & (K Pcs)
    Table 95. Asia Sexual Dysfunction Drugs Sales by Region (2025-2030) & (K Pcs)
    Table 96. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales by Type (2019-2024) & (K Pcs)
    Table 97. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales by Type (2025-2030) & (K Pcs)
    Table 98. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales by User (2019-2024) & (K Pcs)
    Table 101. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales by User (2025-2030) & (K Pcs)
    Table 102. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue by User (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue by User (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales by Country (2019-2024) & (K Pcs)
    Table 108. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales by Country (2025-2030) & (K Pcs)
    Table 109. Pfizer Company Information
    Table 110. Pfizer Description and Major Businesses
    Table 111. Pfizer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 112. Pfizer Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Pfizer Recent Developments
    Table 114. GlaxoSmithKline Company Information
    Table 115. GlaxoSmithKline Description and Major Businesses
    Table 116. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 117. GlaxoSmithKline Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. GlaxoSmithKline Recent Developments
    Table 119. Merck Company Information
    Table 120. Merck Description and Major Businesses
    Table 121. Merck Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 122. Merck Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Merck Recent Developments
    Table 124. Eli Lilly Company Information
    Table 125. Eli Lilly Description and Major Businesses
    Table 126. Eli Lilly Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 127. Eli Lilly Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Eli Lilly Recent Developments
    Table 129. AbbVie Company Information
    Table 130. AbbVie Description and Major Businesses
    Table 131. AbbVie Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 132. AbbVie Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. AbbVie Recent Developments
    Table 134. Bayer Company Information
    Table 135. Bayer Description and Major Businesses
    Table 136. Bayer Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 137. Bayer Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Bayer Recent Developments
    Table 139. Teva Pharmaceutical Industries Company Information
    Table 140. Teva Pharmaceutical Industries Description and Major Businesses
    Table 141. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 142. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Teva Pharmaceutical Industries Recent Developments
    Table 144. Takeda Company Information
    Table 145. Takeda Description and Major Businesses
    Table 146. Takeda Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 147. Takeda Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Takeda Recent Developments
    Table 149. Apricus Biosciences Company Information
    Table 150. Apricus Biosciences Description and Major Businesses
    Table 151. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 152. Apricus Biosciences Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Apricus Biosciences Recent Developments
    Table 154. Emotional Brain Company Information
    Table 155. Emotional Brain Description and Major Businesses
    Table 156. Emotional Brain Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 157. Emotional Brain Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Emotional Brain Recent Developments
    Table 159. Ivix LLX Company Information
    Table 160. Ivix LLX Description and Major Businesses
    Table 161. Ivix LLX Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 162. Ivix LLX Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. Ivix LLX Recent Developments
    Table 164. Leadiant Biosciences Company Information
    Table 165. Leadiant Biosciences Description and Major Businesses
    Table 166. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 167. Leadiant Biosciences Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. Leadiant Biosciences Recent Developments
    Table 169. NexMed Company Information
    Table 170. NexMed Description and Major Businesses
    Table 171. NexMed Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 172. NexMed Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 173. NexMed Recent Developments
    Table 174. S1 Biopharma Company Information
    Table 175. S1 Biopharma Description and Major Businesses
    Table 176. S1 Biopharma Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 177. S1 Biopharma Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 178. S1 Biopharma Recent Developments
    Table 179. Vietstar Biomedical Research Company Information
    Table 180. Vietstar Biomedical Research Description and Major Businesses
    Table 181. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 182. Vietstar Biomedical Research Sexual Dysfunction Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 183. Vietstar Biomedical Research Recent Developments
    Table 184. Key Raw Materials Lists
    Table 185. Raw Materials Key Suppliers Lists
    Table 186. Sexual Dysfunction Drugs Distributors List
    Table 187. Sexual Dysfunction Drugs Customers List
    Table 188. Sexual Dysfunction Drugs Market Trends
    Table 189. Sexual Dysfunction Drugs Market Drivers
    Table 190. Sexual Dysfunction Drugs Market Challenges
    Table 191. Sexual Dysfunction Drugs Market Restraints
    Table 192. Research Programs/Design for This Report
    Table 193. Key Data Information from Secondary Sources
    Table 194. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sexual Dysfunction Drugs Product Picture
    Figure 2. Global Sexual Dysfunction Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sexual Dysfunction Drugs Market Share by Type in 2023 & 2030
    Figure 4. Oral Therapy Product Picture
    Figure 5. Intracavernosal Therapy Product Picture
    Figure 6. Hormonal Therapy Product Picture
    Figure 7. Transurethral Therapy Product Picture
    Figure 8. Global Sexual Dysfunction Drugs Market Size Growth Rate by User, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Sexual Dysfunction Drugs Market Share by User in 2023 & 2030
    Figure 10. Male
    Figure 11. Female
    Figure 12. Sexual Dysfunction Drugs Report Years Considered
    Figure 13. Global Sexual Dysfunction Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Sexual Dysfunction Drugs Revenue 2019-2030 (US$ Million)
    Figure 15. Global Sexual Dysfunction Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2019-2030)
    Figure 17. Global Sexual Dysfunction Drugs Sales 2019-2030 ((K Pcs)
    Figure 18. Global Sexual Dysfunction Drugs Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Sexual Dysfunction Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 20. US & Canada Sexual Dysfunction Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Sexual Dysfunction Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 22. Europe Sexual Dysfunction Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Sexual Dysfunction Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 24. China Sexual Dysfunction Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Sexual Dysfunction Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 26. Asia (excluding China) Sexual Dysfunction Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales YoY (2019-2030) & (K Pcs)
    Figure 28. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Sexual Dysfunction Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Sexual Dysfunction Drugs in the World: Market Share by Sexual Dysfunction Drugs Revenue in 2023
    Figure 31. Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Sexual Dysfunction Drugs Sales Market Share by Type (2019-2030)
    Figure 33. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2030)
    Figure 34. Global Sexual Dysfunction Drugs Sales Market Share by User (2019-2030)
    Figure 35. Global Sexual Dysfunction Drugs Revenue Market Share by User (2019-2030)
    Figure 36. US & Canada Sexual Dysfunction Drugs Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Sexual Dysfunction Drugs Sales Market Share by User (2019-2030)
    Figure 39. US & Canada Sexual Dysfunction Drugs Revenue Market Share by User (2019-2030)
    Figure 40. US & Canada Sexual Dysfunction Drugs Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Sexual Dysfunction Drugs Sales Share by Country (2019-2030)
    Figure 42. U.S. Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Sexual Dysfunction Drugs Sales Market Share by Type (2019-2030)
    Figure 45. Europe Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Sexual Dysfunction Drugs Sales Market Share by User (2019-2030)
    Figure 47. Europe Sexual Dysfunction Drugs Revenue Market Share by User (2019-2030)
    Figure 48. Europe Sexual Dysfunction Drugs Revenue Share by Country (2019-2030)
    Figure 49. Europe Sexual Dysfunction Drugs Sales Share by Country (2019-2030)
    Figure 50. Germany Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 51. France Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 55. China Sexual Dysfunction Drugs Sales Market Share by Type (2019-2030)
    Figure 56. China Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2030)
    Figure 57. China Sexual Dysfunction Drugs Sales Market Share by User (2019-2030)
    Figure 58. China Sexual Dysfunction Drugs Revenue Market Share by User (2019-2030)
    Figure 59. Asia Sexual Dysfunction Drugs Sales Market Share by Type (2019-2030)
    Figure 60. Asia Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Sexual Dysfunction Drugs Sales Market Share by User (2019-2030)
    Figure 62. Asia Sexual Dysfunction Drugs Revenue Market Share by User (2019-2030)
    Figure 63. Asia Sexual Dysfunction Drugs Revenue Share by Region (2019-2030)
    Figure 64. Asia Sexual Dysfunction Drugs Sales Share by Region (2019-2030)
    Figure 65. Japan Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 69. India Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales Market Share by User (2019-2030)
    Figure 73. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue Market Share by User (2019-2030)
    Figure 74. Middle East, Africa and Latin America Sexual Dysfunction Drugs Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Sexual Dysfunction Drugs Sales Share by Country (2019-2030)
    Figure 76. Brazil Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Sexual Dysfunction Drugs Revenue (2019-2030) & (US$ Million)
    Figure 81. Sexual Dysfunction Drugs Value Chain
    Figure 82. Sexual Dysfunction Drugs Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed